Search
GSK-1292263
go.drugbank.com/drugs/DB12627InvestigationalGSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Edivoxetine
go.drugbank.com/drugs/DB09184InvestigationalEdivoxetine failed to be approved for major depressive disorder after phase III clinical trials in 2012. … Edivoxetine is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant
UB-612
go.drugbank.com/drugs/DB16444InvestigationalIn rats, toxicity studies have so far shown favourable safety for this vaccine[L30653, L30658], Phase 1 trial is currently ongoing in Taiwan (NCT04545749). … In addition, the vaccine contains a proprietary peptide UBITh®1a for enhanced immunogenicity, five identified peptides with Th or CTL epitopes to improve peptide solubility, and aluminum phosphate adjuvant
Solanezumab
go.drugbank.com/drugs/DB11756InvestigationalSolanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
NXC680
go.drugbank.com/drugs/DB18366ExperimentalNXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).
FLX475
go.drugbank.com/drugs/DB15570InvestigationalFLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.[L9875]
Glucagon-like peptide II
go.drugbank.com/drugs/DB12788InvestigationalGlucagon-like peptide II is under investigation for the basic science of Short Bowel Syndrome.
Urocortin-2
go.drugbank.com/drugs/DB13033InvestigationalUrocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
Pimonidazole
go.drugbank.com/drugs/DB12485InvestigationalPimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer.
Talaporfin
go.drugbank.com/drugs/DB11812InvestigationalTalaporfin has been investigated for the treatment of Port-Wine Stain and Benign Prostatic Hyperplasia.